Hostname: page-component-848d4c4894-ttngx Total loading time: 0 Render date: 2024-05-12T20:47:34.252Z Has data issue: false hasContentIssue false

Blood levels of the omega-3 fatty acid docosahexaenoic acid are associated with gait and lower limb power in older females

Published online by Cambridge University Press:  22 April 2015

S. C. Dyall
Affiliation:
Department of Life Sciences, University of Roehampton, London SW15 4JD UK
A. Carlisle
Affiliation:
Department of Life Sciences, University of Roehampton, London SW15 4JD UK
E. L. Gibson
Affiliation:
Department of Psychology, University of Roehampton, London SW15 4JD UK
S. Strike
Affiliation:
Department of Life Sciences, University of Roehampton, London SW15 4JD UK
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2015 

Walking performance is a key determinant of frailty in older adults( Reference Rothman, Leo-Summers and Gill 1 ) and reduced muscle strength in walking is associated with poor motor performance, postural instability and a risk of falling amongst older adults and may dissuade individuals from activity participation. Vertical Jump Height (VJH) analysis is a useful movement model and has been studied extensively in relation to muscle power and strength. Omega-3 fatty acid supplementation improves walking speed in older females( Reference Hutchins-Wiese, Kleppinger and Annis 2 ), and may represent a potential intervention for the prevention and treatment of sarcopenia( Reference Smith, Atherton and Reeds 3 ). The present study analysed the relationship between blood levels of the omega-3 fatty acid, docosahexaenoic acid (DHA) and gait, functional strength and lower limb power in older females.

A Vicon 9 motion capture camera system synchronised with Kistler force plates was used to analyse the relationship between self-selected habitual (normal) and fast walking and VJH and blood levels of DHA in 28 postmenopausal women (mean age 67 years, S.D. 6 years). Liner regression models were performed for the movement outcome variables, with whole-blood DHA content (% total fatty acids) the predictor variable. Other factors included in the models were age, Body Mass Index (BMI), self-reported physical activity (PASE)( Reference Washburn, Smith and Jette 4 ) and grip strength.

With normal walking there were no significant effects for BMI, age or grip strength and these were progressively removed from the model based on the largest P values and the analysis repeated. DHA (Fig. 1) (coefficient 0·10, [95% CI 0·41, 0·16], P = 0·002) and PASE (0·003, [0·00, 0·00], P = 0·001) remained significant, with the model explaining 51% of the variance. Similarly for fast walking the only significant effects were also with DHA (0·14, [0·07, 0·21], P < 0·001) (Fig. 2) and PASE (0·002, [0·00, 00], P < 0·05), explaining 46% of the variance. With VJH the effects of age, DHA (Fig. 3) and BMI remained significant after adjustments (−0·32, [−0·54, 0·10], P = 0·07), (1·92, [0·72, 3·13], P = 0·003) and (−0·76, [−1·16, −0·37], P = 0·001), respectively, explaining 69% of the variance.

Fig. 1 Fast walk

Fig. 2 Normal walk

Fig. 3 VJH

These results show that with both self-selected habitual and fast walking speeds higher circulating DHA along with physical activity levels are important contributory factors. Higher circulating DHA is also associated with high power, high velocity movements, assessed using VJH, though here, the high demand movement was also related to age and BMI. Interestingly, grip strength was not a factor for any movement, suggesting that hand grip strength is not related to whole-body functional movement strength and power.

This work was supported by Efamol Ltd/Wassen Intl Ltd.

References

1. Rothman, MD, Leo-Summers, L, Gill, TM. (2008). J Am Geriatr Soc. 56, 2211–116.Google Scholar
2. Hutchins-Wiese, HL, Kleppinger, A, Annis, K, et al. (2013). J Nutr Health Aging. 17, 7680.Google Scholar
3. Smith, GI, Atherton, P, Reeds, DN, et al. (2011). Am J Clin Nutr. 93, 402–12.Google Scholar
4. Washburn, RA, Smith, KW, Jette, AM, et al. (1993). J Clin Epidemiol. 46, 153–62.Google Scholar
Figure 0

Fig. 1 Fast walk

Figure 1

Fig. 2 Normal walk

Figure 2

Fig. 3 VJH